Zacks Investment Research Downgrades Concord Medical Services (CCM) to Hold
Zacks Investment Research cut shares of Concord Medical Services (NYSE:CCM) from a buy rating to a hold rating in a research report released on Thursday.
According to Zacks, “Concord Medical Services Holdings Limited operates a large network of radiotherapy and diagnostic imaging centers in China. Most of the centers in their network are established through long-term lease and management services arrangements entered into with their hospital partners. Under these arrangements, Concord Medical receives a contracted percentage of each center’s revenue net of specified operating expenses. Each center is located on the premises of their hospital partners and is typically equipped with a primary unit of advanced radiotherapy or diagnostic imaging equipment, such as a linear accelerator, head gamma knife system, body gamma knife system, PET-CT scanner or MRI scanner. “
Concord Medical Services stock traded down $0.03 on Thursday, reaching $3.10. The company’s stock had a trading volume of 1,445 shares, compared to its average volume of 8,050. Concord Medical Services has a one year low of $2.46 and a one year high of $4.83. The company has a current ratio of 1.60, a quick ratio of 1.59 and a debt-to-equity ratio of 0.20.
About Concord Medical Services
Concord Medical Services Holdings Limited is engaged in the leasing of radiotherapy and diagnostic imaging equipment, the provision of management services to hospitals. The Company is also engaged in hospital operations. The Company’s segments are network and premium cancer hospital. The Company operates a network of radiotherapy and diagnostic imaging centers in China.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.